MARKET

TRIB

TRIB

Trinity Biotech Plc
NASDAQ
1.242
-0.048
-3.72%
Opening 10:55 12/08 EST
OPEN
1.260
PREV CLOSE
1.290
HIGH
1.260
LOW
1.208
VOLUME
2.06K
TURNOVER
2.29K
52 WEEK HIGH
1.990
52 WEEK LOW
0.8600
MARKET CAP
47.33M
P/E (TTM)
-2.0045
1D
5D
1M
3M
1Y
5Y
Trinity Biotech to participate in the Piper Sandler 34th Annual Healthcare Conference
DUBLIN, Ireland, Nov. 30, 2022 (GLOBE NEWSWIRE) -- Trinity Biotech (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, is scheduled to participate in the Piper Sandler 34th Annu...
GlobeNewswire · 11/30 10:50
BRIEF-Trinity Biotech Reports Quarterly Total Revenues Of $18.5 Million
Reuters · 11/03 14:13
Trinity Biotech GAAP EPS of -$28.60, revenue of $18.5M
Seekingalpha · 11/03 13:10
Trinity Biotech Q2 Sales $18.50M Down From $25.84M YoY
Benzinga · 11/03 13:02
Trinity Biotech Announces Quarter 2 2022 Financial Results And Preliminary Q3 2022 Revenue Guidance
DUBLIN, Ireland, Nov. 03, 2022 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced the Company’s results for the quarter ...
GlobeNewswire · 11/03 13:00
Trinity Biotech plc to Announce Second Quarter Fiscal Year 2022 Financial Results
Conference Call Scheduled for November 3, 2022 at 11:00 am EASTERNDUBLIN, Ireland, Nov. 01, 2022 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laborato...
GlobeNewswire · 11/01 13:15
BRIEF-Trinity Biotech Announces The Appointment Of Tom Lindsay To Its Board
Reuters · 10/26 13:11
Trinity Biotech appoints former GE executive Aris Kekedjian as CEO
Trinity Biotech (NASDAQ:TRIB) on Monday said it had appointed...
Seekingalpha · 10/03 13:55
More
About TRIB
Trinity Biotech Public Limited Company through its subsidiaries develops, acquires, manufactures and markets medical diagnostic products for the clinical laboratory and point-of-care (POC)segments of the diagnostic market. The Company's products are used to detect autoimmune, infectious and sexually transmitted diseases, diabetes and disorders of the liver and intestine. It operates through two segments: the Americas and Rest of World. Its products are classified as POC, emergency medicine, clinical laboratory and blood bank screening. Its POC brands include Uni-Gold and Recombigen. Emergency medicine diagnostics refer to its acute care testing, STAT labs, pre/post-operative units, physician office labs and the central laboratory. Trinity Biotech supplies clinical laboratory market with reagent products and other products through its clinical chemistry business.

Webull offers kinds of Trinity Biotech plc (ADR) stock information, including NASDAQ:TRIB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TRIB stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading TRIB stock methods without spending real money on the virtual paper trading platform.